Search results for ruxolitinib

377 hits were found for ruxolitinib

# Family MCID Name MIFTS Score
1
MYL005 Myelofibrosis 70 0.711
2
P PLY018 Polycythemia 56 0.441
3
PLY001 Polycythemia Vera 69 0.436
4
SPL018 Splenomegaly 48 0.374
5
P GRF003 Graft-Versus-Host Disease 72 0.347
6
MYL031 Myeloproliferative Neoplasm 66 0.343
7
P ESS003 Essential Thrombocythemia 68 0.330
8
P LKM002 Leukemia 68 0.322
9
c PRM012 Primary Polycythemia 50 0.316
10
c THR090 Thrombocythemia 1 49 0.283
11
P MYL006 Myeloid Leukemia 60 0.263
12
c ACT135 Acute Graft Versus Host Disease 52 0.250
13
THR004 Thrombocytosis 51 0.250
14
P LYM118 Lymphoma 68 0.224
15
BNM001 Bone Marrow Cancer 43 0.224
16
CYT002 Cytokine Deficiency 42 0.213
17
P THR014 Thrombocytopenia 67 0.211
18
CVD001 Covid-19 44 0.211
19
LYM019 Lymphosarcoma 46 0.208
20
c LKM061 Leukemia, Acute Myeloid 84 0.206
21
c CHR417 Chronic Graft Versus Host Disease 57 0.203
22
HML018 Homologous Wasting Disease 22 0.194
23
DWN001 Down Syndrome 70 0.189
24
c CHR064 Chronic Monocytic Leukemia 33 0.186
25
c LKM063 Leukemia, Chronic Myeloid 72 0.176
26
P PRT133 Proteasome-Associated Autoinflammatory Syndrome 1 81 0.173
27
P LKM062 Leukemia, Acute Lymphoblastic 69 0.170
28
c SVR001 Severe Acute Respiratory Syndrome 62 0.163
29
P HMP002 Hemophagocytic Lymphohistiocytosis 54 0.163
30
ACT113 Acute Myeloblastic Leukemia with Maturation 46 0.163
31
ADL002 Adult Syndrome 70 0.160
32
P TRN020 Turner Syndrome 67 0.160
33
P ALP008 Alopecia 54 0.160
34
PPL061 Papular Epidermal Nevi with Skyline Basal Cell Layers Syndrome 25 0.160
35
MYL009 Myelodysplastic Syndrome 70 0.153
36
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 57 0.153
37
P PNM007 Pneumonia 68 0.149
38
c RHB024 Rhabdomyosarcoma 2 67 0.145
39
P NTR004 Neutropenia 63 0.145
40
48X005 48,xyyy 39 0.145
41
P DRM053 Dermatitis, Atopic 66 0.141
42
DRM006 Dermatitis 61 0.141
43
c ACT073 Acute Leukemia 58 0.141
44
P BRS047 Breast Cancer 97 0.137
45
LYM133 Lymphoma, Hodgkin, Classic 69 0.137
46
P ADN016 Adenocarcinoma 64 0.137
47
P PNC035 Pancreatic Cancer 84 0.133
48
P PSR002 Psoriasis 62 0.129
49
LYM040 Lymphoblastic Lymphoma 54 0.129
50
PST011 Pustulosis of Palm and Sole 52 0.129
51
P ALP009 Alopecia Areata 60 0.125
52
c PSR017 Psoriasis 2 53 0.125
53
c PSR023 Psoriasis 1 52 0.125
54
c PSR032 Psoriasis 11 47 0.125
55
c DRM054 Dermatitis, Atopic, 2 44 0.125
56
c PSR028 Psoriasis 7 42 0.125
57
c PSR018 Psoriasis 13 41 0.125
58
MYL069 Myeloma, Multiple 85 0.120
59
P ADL010 Adult Respiratory Distress Syndrome 65 0.120
60
P VTL004 Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1 60 0.120
61
c VTL009 Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6 42 0.120
62
P LNG032 Lung Cancer 98 0.111
63
P LKM071 Leukemia, Chronic Lymphocytic 79 0.111
64
P RSP003 Respiratory Failure 74 0.111
65
DFC004 Deficiency Anemia 70 0.111
66
ANM044 Anemia, X-Linked, with or Without Neutropenia and/or Platelet Abnormalities 67 0.111
67
P CHR285 Chronic Myelomonocytic Leukemia 60 0.111
68
NWB001 Newborn Respiratory Distress Syndrome 58 0.111
69
MYL075 Myelodysplastic/myeloproliferative Neoplasm 49 0.111
70
CHR286 Chronic Neutrophilic Leukemia 42 0.111
71
ALP097 Alopecia Universalis Congenita 59 0.105
72
P BCL017 B-Cell Lymphoma 58 0.105
73
PLS009 Plasma Cell Neoplasm 51 0.105
74
c LKM056 Leukemia, Chronic Lymphocytic 2 48 0.105
75
P SRC025 Sarcoidosis 1 70 0.100
76
c HMP022 Hemophagocytic Lymphohistiocytosis, Familial, 1 63 0.100
77
SQM006 Squamous Cell Carcinoma 60 0.100
78
P DRM010 Dermatomyositis 61 0.094
79
SPN041 Spinal Cord Disease 56 0.094
80
RTN193 Retinitis Pigmentosa and Erythrocytic Microcytosis 52 0.094
81
ATY042 Atypical Chronic Myeloid Leukemia 49 0.094
82
MRG013 Mirage Syndrome 43 0.094
83
P OVR042 Ovarian Cancer 88 0.088
84
P INF038 Influenza 68 0.088
85
PNC129 Pancreatic Adenocarcinoma 68 0.088
86
c SML038 Small Cell Cancer of the Lung 65 0.088
87
c JVN010 Juvenile Rheumatoid Arthritis 64 0.088
88
CHR063 Chronic Mucocutaneous Candidiasis 63 0.088
89
ATM095 Autoimmune Disease 62 0.088
90
VRL011 Viral Infectious Disease 61 0.088
91
P LYM033 Lymphoproliferative Syndrome 59 0.088
92
P CND004 Candidiasis 58 0.088
93
NTR018 Neutrophilia, Hereditary 52 0.088
94
HDG002 Hodgkin's Lymphoma, Lymphocytic-Histiocytic Predominance 42 0.088
95
c SCN069 Secondary Hemophagocytic Lymphohistiocytosis 33 0.088
96
PDG002 Pdgfrb-Associated Chronic Eosinophilic Leukemia 27 0.088
97
HDG004 Hodgkin's Granuloma 23 0.088
98
HDG006 Hodgkin's Paragranuloma 22 0.088
99
SQM013 Squamous Cell Carcinoma, Head and Neck 80 0.082
100
LYM143 Lymphoma, Non-Hodgkin, Familial 72 0.082
101
FCT007 Factor Vii Deficiency 67 0.082
102
P HYP098 Hypereosinophilic Syndrome 67 0.082
103
P MNN013 Meningitis 66 0.082
104
BRN002 Bronchiolitis 59 0.082
105
BRN012 Bronchiolitis Obliterans 55 0.082
106
47X002 47,xyy 49 0.082
107
P CLR023 Colorectal Cancer 99 0.075
108
GLB015 Glioblastoma Multiforme 75 0.075
109
c JVN004 Juvenile Myelomonocytic Leukemia 67 0.075
110
SRC014 Sarcoma 65 0.075
111
P ART062 Arthrogryposis, Renal Dysfunction, and Cholestasis 1 65 0.075
112
HMT002 Hematologic Cancer 62 0.075
113
ALL026 Allergic Hypersensitivity Disease 62 0.075
114
THR024 Thrombosis 57 0.075
115
P ADL017 Adult T-Cell Leukemia 56 0.075
116
SPN035 Spindle Cell Sarcoma 53 0.075
117
c VRL005 Viral Pneumonia 52 0.075
118
c INF023 Inflammatory Breast Carcinoma 50 0.075
119
WTH001 Withdrawal Disorder 48 0.075
120
TCL028 T-Cell Lymphoblastic Leukemia/lymphoma 47 0.075
121
c BDY007 Body Mass Index Quantitative Trait Locus 1 42 0.075
122
c LKM005 Leukemia, T-Cell, Chronic 34 0.075
123
ALP048 Alopecia Totalis 32 0.075
124
P PRS040 Prostate Cancer 97 0.067
125
P LNG064 Lung Cancer Susceptibility 3 78 0.067
126
P MLN008 Melanoma 69 0.067
127
SKN019 Skin Melanoma 68 0.067
128
ALP042 Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity 66 0.067
129
P SKN015 Skin Carcinoma 66 0.067
130
SKN016 Skin Disease 63 0.067
131
P LPS004 Lupus Erythematosus 61 0.067
132
P THL005 Thalassemia 60 0.067
133
c HPT016 Hepatitis B 59 0.067
134
LYM027 Lymphopenia 58 0.067
135
DFF005 Diffuse Large B-Cell Lymphoma 55 0.067
136
ACT193 Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22) 54 0.067
137
P LCH002 Lichen Planus 53 0.067
138
c MLN055 Melanoma, Cutaneous Malignant 10 52 0.067
139
c CHR418 Chronic Leukemia 49 0.067
140
TRP009 Triple X Syndrome 42 0.067
141
ATX019 Ataxia with Vitamin E Deficiency 42 0.067
142
c PRS136 Prostate Cancer, Hereditary, 6 33 0.067
143
c PRS130 Prostate Cancer, Hereditary, 8 32 0.067
144
P GLM040 Glioma Susceptibility 1 81 0.058
145
P RHM011 Rheumatoid Arthritis 80 0.058
146
IMM167 Immune Deficiency Disease 78 0.058
147
KPS004 Kaposi Sarcoma 75 0.058
148
BRN028 Brain Cancer 74 0.058
149
END057 Endometrial Cancer 74 0.058
150
c BTT014 Beta-Thalassemia 74 0.058
151
SVR004 Severe Combined Immunodeficiency 73 0.058
152
P CNR004 Cone-Rod Dystrophy 2 73 0.058
153
P MYC084 Mycobacterium Tuberculosis 1 68 0.058
154
FLL027 Fallopian Tube Carcinoma 67 0.058
155
P MST009 Mastocytosis 64 0.058
156
c ALP101 Alpha-Thalassemia 62 0.058
157
PRM126 Primary Peritoneal Carcinoma 62 0.058
158
BRS099 Breast Ductal Carcinoma 62 0.058
159
HRP004 Herpes Zoster 60 0.058
160
INT066 Interstitial Lung Disease 60 0.058
161
LNG099 Lung Disease 60 0.058
162
CHC001 Chickenpox 60 0.058
163
DCT002 Ductal Carcinoma in Situ 59 0.058
164
BRS051 Breast Disease 58 0.058
165
P PRP019 Peripheral Nervous System Disease 58 0.058
166
GLS018 Glass Syndrome 57 0.058
167
IRN002 Iron Metabolism Disease 57 0.058
168
MLT161 Multinucleated Neurons, Anhydramnios, Renal Dysplasia, Cerebellar Hypoplasia, and Hydranencephaly 57 0.058
169
c LKM060 Leukemia, Acute Lymphoblastic 3 56 0.058
170
P NRP001 Neuropathy 56 0.058
171
P DRR001 Diarrhea 55 0.058
172
EPT010 Epithelial-Myoepithelial Carcinoma 55 0.058
173
HMS001 Hemosiderosis 54 0.058
174
PNC001 Pancytopenia 54 0.058
175
P INS002 in Situ Carcinoma 53 0.058
176
SRS001 Serous Cystadenocarcinoma 52 0.058
177
TCL027 T-Cell Acute Lymphoblastic Leukemia 51 0.058
178
CYS014 Cystadenocarcinoma 51 0.058
179
c BRS049 Breast Carcinoma in Situ 51 0.058
180
FSC004 Fasciitis 50 0.058
181
TRP002 Tropical Spastic Paraparesis 50 0.058
182
CLR003 Clear Cell Adenocarcinoma 50 0.058
183
TCL023 T-Cell Lymphoma, Subcutaneous Panniculitis-Like 50 0.058
184
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 48 0.058
185
RTC005 Reticulosarcoma 47 0.058
186
c HMN021 Human T-Cell Leukemia Virus Type 1 47 0.058
187
CMP090 Complement Component 3 Deficiency, Autosomal Recessive 45 0.058
188
IMM136 Immune System Disease 45 0.058
189
CLL014 Cll/sll 45 0.058
190
APP009 Appendix Adenocarcinoma 44 0.058
191
PRT035 Peritoneum Cancer 44 0.058
192
49X006 49, Xxxxy Syndrome 41 0.058
193
c PRM163 Primary Mediastinal Large B-Cell Lymphoma 41 0.058
194
P RRH023 Rare Hereditary Hemochromatosis 41 0.058
195
MYL057 Myelopathy, Htlv-1-Associated 39 0.058
196
SPS019 Spastic Paraparesis 38 0.058
197
MYL067 Myeloproliferative Disorder, Chronic, with Eosinophilia 37 0.058
198
HTL001 Htlv-1 Associated Myelopathy/tropical Spastic Paraparesis 35 0.058
199
SYN063 Syndactyly, Mesoaxial Synostotic, with Phalangeal Reduction 35 0.058
201
FLL022 Fallopian Tube Clear Cell Adenocarcinoma 28 0.058
202
FTL073 Fetal Anticonvulsant Syndrome 26 0.058
203
VNH007 Von Hippel-Lindau Syndrome 73 0.047
204
c CHR684 Chronic Kidney Disease 70 0.047
205
c NRD033 Neurodegeneration with Brain Iron Accumulation 2a 69 0.047
206
PLM001 Pulmonary Tuberculosis 69 0.047
207
P ART022 Arthritis 69 0.047
208
P HPT021 Hepatitis 67 0.047
209
P PLM037 Pulmonary Hypertension 67 0.047
210
P HRP006 Herpes Simplex 65 0.047
211
GST106 Gastrointestinal Ulceration, Recurrent, with Dysfunctional Platelets 64 0.047
212
P GLM045 Glioma 63 0.047
213
P BLD124 Bleeding Disorder, Platelet-Type, 11 63 0.047
214
BDD001 Budd-Chiari Syndrome 63 0.047
215
c FNC043 Fanconi Anemia, Complementation Group E 62 0.047
216
P HYP750 Hypertriglyceridemia, Familial 62 0.047
217
HYP810 Hypereosinophilic Syndrome, Idiopathic 62 0.047
218
TXC005 Toxic Shock Syndrome 62 0.047
219
c JVN061 Juvenile Arthritis 60 0.047
220
P TXP001 Toxoplasmosis 60 0.047
221
END081 Endosteal Hyperostosis, Autosomal Dominant 60 0.047
222
SPP011 Suppression of Tumorigenicity 12 59 0.047
223
PRG009 Progressive Multifocal Leukoencephalopathy 59 0.047
224
P ERY058 Erythrocytosis, Familial, 1 59 0.047
225
c CHL140 Chilblain Lupus 1 58 0.047
226
RSP019 Respiratory Distress Syndrome in Premature Infants 58 0.047
227
INT324 Intrauterine Growth Retardation, Metaphyseal Dysplasia, Adrenal Hypoplasia Congenita, and Genital Anomalies 58 0.047
228
ADL030 Adult-Onset Still's Disease 58 0.047
229
CHL028 Childhood Type Dermatomyositis 58 0.047
230
P BNC003 Bone Cancer 58 0.047
231
P EXN002 Exanthem 57 0.047
232
BCL010 B-Cell Expansion with Nfkb and T-Cell Anergy 57 0.047
233
PLS011 Plasmacytoma 56 0.047
234
BCT022 Bacterial Infectious Disease 56 0.047
235
SFT003 Soft Tissue Sarcoma 56 0.047
236
c ERY071 Erythrocytosis, Familial, 2, Autosomal Recessive 55 0.047
237
HMN014 Human Immunodeficiency Virus Infectious Disease 55 0.047
238
HDR002 Hidradenitis Suppurativa 55 0.047
239
PLS016 Plasma Cell Leukemia 53 0.047
240
PRP036 Peripheral T-Cell Lymphoma 53 0.047
241
P PLM006 Pulmonary Alveolar Proteinosis 53 0.047
242
P MSC003 Muscular Atrophy 52 0.047
243
LNG031 Lung Benign Neoplasm 51 0.047
244
STM007 Stomatitis 50 0.047
245
c ACQ017 Acquired Von Willebrand Syndrome 49 0.047
246
HDR003 Hidradenitis 49 0.047
247
LYM138 Lymphoblastic Leukemia, Acute, with Lymphomatous Features 49 0.047
248
MNN009 Meningoencephalitis 49 0.047
249
CRY014 Cryptococcal Meningitis 48 0.047
250
CHR661 Choreoathetosis and Congenital Hypothyroidism with or Without Pulmonary Dysfunction 48 0.047
251
CHR563 Chronic Eosinophilic Leukemia 48 0.047
252
MNC006 Monoclonal Gammopathy of Uncertain Significance 48 0.047
253
P ERY008 Erythromelalgia 47 0.047
254
WRN003 Wernicke Encephalopathy 47 0.047
255
RTN023 Retinitis 46 0.047
256
c DRR009 Diarrhea 6 46 0.047
257
c MLG068 Malignant Glioma 46 0.047
258
GLL048 Glial Tumor 45 0.047
259
MXD026 Mixed Glioma 45 0.047
260
CHL152 Childhood Acute Lymphocytic Leukemia 44 0.047
261
MDD018 Middle East Respiratory Syndrome 43 0.047
262
NRR001 Neuroretinitis 42 0.047
263
CRN322 Coronavirus Infectious Disease 40 0.047
264
P MLG074 Malignant Mesenchymoma 40 0.047
265
CMP080 Complement Hyperactivation, Angiopathic Thrombosis, and Protein-Losing Enteropathy 38 0.047
266
SPS226 Spastic Paraplegia, Ataxia, and Mental Retardation 37 0.047
267
ATM052 Autoimmune Disease 1 37 0.047
268
CHR028 Chronic Wasting Disease 35 0.047
269
c TCL024 T-Cell Non-Hodgkin Lymphoma 34 0.047
270
SML011 Smoldering Myeloma 33 0.047
271
ENC065 Encephalitis/encephalopathy, Mild, with Reversible Myelin Vacuolization 33 0.047
272
RSP007 Respiratory Distress Syndrome, Infant 30 0.047
273
TMR016 Tumor Suppressor Gene on Chromosome 11 28 0.047
274
BRN101 Bronchiolitis Obliterans with Obstructive Pulmonary Disease 27 0.047
275
c PNC132 Pancreatic Cancer 5 22 0.047
276
P HPT023 Hepatocellular Carcinoma 100 0.033
277
c NRF023 Neurofibromatosis, Type Ii 80 0.033
278
c PLM164 Pulmonary Hypertension, Primary, 1 75 0.033
279
c THR092 Thrombophilia Due to Thrombin Defect 73 0.033
280
P KDN018 Kidney Disease 72 0.033
281
HMN044 Human Immunodeficiency Virus Type 1 71 0.033
282
P AMY004 Amyloidosis 70 0.033
283
GST040 Gastric Adenocarcinoma 70 0.033
284
P ASP006 Aspergillosis 69 0.033
285
P SYS005 Systemic Scleroderma 68 0.033
286
c BSL007 Basal Cell Carcinoma 68 0.033
287
P MYS003 Myasthenia Gravis 68 0.033
288
BRN024 Bronchitis 68 0.033
289
ANG054 Angina Pectoris 66 0.033
290
GRG001 Greig Cephalopolysyndactyly Syndrome 66 0.033
291
HTC003 Hutchinson-Gilford Progeria Syndrome 65 0.033
292
MRK001 Merkel Cell Carcinoma 65 0.033
293
PRT036 Peritonitis 64 0.033
294
c MLG084 Malignant Fibrous Histiocytoma 63 0.033
295
ACT119 Acute Promyelocytic Leukemia 63 0.033
296
c SYS004 Systemic Mastocytosis 63 0.033
297
CLT003 Colitis 62 0.033
298
NRM001 Neuromyelitis Optica 61 0.033
299
c SCL052 Scleroderma, Familial Progressive 61 0.033
300
P ENC018 Encephalopathy 61 0.033
301
P ENC004 Encephalitis 61 0.033
302
P PNC044 Pancreatitis 61 0.033
303
P NPH012 Nephrotic Syndrome 60 0.033
304
c ACT027 Acute Pancreatitis 60 0.033
305
VRC005 Varicose Veins 60 0.033
306
PRT013 Portal Hypertension 59 0.033
307
ADN018 Adenoma 59 0.033
308
CRY005 Cryptococcosis 58 0.033
309
CCC001 Coccidioidomycosis 58 0.033
310
P URT039 Urticaria 58 0.033
311
CNS004 Constipation 58 0.033
312
c DWL002 Dowling-Degos Disease 1 58 0.033
313
LNG108 Langerhans Cell Histiocytosis 58 0.033
314
LYM021 Lymphadenitis 57 0.033
315
APH002 Aphasia 57 0.033
316
CYT008 Cytomegalovirus Infection 57 0.033
317
CMR002 Coumarin Resistance 56 0.033
318
ERY051 Erythroleukemia, Familial 56 0.033
319
MCS002 Mucositis 56 0.033
320
AGN016 Aging 56 0.033
321
HST011 Histoplasmosis 55 0.033
322
HYP005 Hypokalemia 55 0.033
323
BRN014 Bronchopneumonia 54 0.033
324
c ATM082 Autoimmune Lymphoproliferative Syndrome, Type V 54 0.033
325
PRC013 Pericarditis 54 0.033
326
P MNC007 Monocytic Leukemia 53 0.033
327
P HMR003 Hemorrhagic Disease 53 0.033
328
P CTN003 Cutaneous Lupus Erythematosus 53 0.033
329
GST023 Gastric Ulcer 53 0.033
330
FDL002 Food Allergy 51 0.033
331
ENT011 Enterocolitis 51 0.033
332
ESP002 Esophageal Varix 51 0.033
333
PNN001 Panniculitis 51 0.033
334
PNC041 Pancreatic Ductal Adenocarcinoma 51 0.033
335
PTT041 Pituitary Stalk Interruption Syndrome 50 0.033
336
LNT004 Lentigines 50 0.033
337
P OVR082 Overgrowth Syndrome 50 0.033
338
CYT005 Cytomegalovirus Retinitis 50 0.033
339
MLL001 Molluscum Contagiosum 50 0.033
340
HYP017 Hypophosphatemia 50 0.033
341
BLD053 Blood Platelet Disease 49 0.033
342
P EST001 Estrogen-Receptor Positive Breast Cancer 49 0.033
343
PRN014 Paronychia 49 0.033
344
AGG002 Aggressive Systemic Mastocytosis 49 0.033
345
c TCL005 T-Cell Prolymphocytic Leukemia 49 0.033
346
c INV001 Invasive Aspergillosis 49 0.033
347
MLR002 Miliary Tuberculosis 49 0.033
348
HST010 Histiocytosis 48 0.033
349
NCR007 Necrotizing Fasciitis 48 0.033
350
RFR010 Refractory Anemia 48 0.033
351
BLY001 B-Lymphoblastic Leukemia/lymphoma 48 0.033
352
P KRT005 Keratoacanthoma 48 0.033
353
PRL017 Prolymphocytic Leukemia 47 0.033
354
NRN001 Neuroendocrine Carcinoma 47 0.033
355
LYM009 Lymphocytic Choriomeningitis 47 0.033
356
P BLD051 Blood Coagulation Disease 46 0.033
357
URT010 Ureteral Obstruction 45 0.033
358
c MYL058 Myeloproliferative Syndrome, Transient 44 0.033
359
MCR225 Macrophage Activation Syndrome 44 0.033
360
LTH001 Lethal Midline Granuloma 44 0.033
361
CHL149 Childhood Acute Myeloid Leukemia 44 0.033
362
NTM002 Nut Midline Carcinoma 44 0.033
363
BCT021 Bacterial Sepsis 44 0.033
364
P PRM293 Primary Mediastinal B-Cell Lymphoma 43 0.033
365
TST015 Testicular Disease 43 0.033
366
NSP002 Nasopharyngitis 43 0.033
367
MYC013 Mycobacterium Abscessus 43 0.033
368
PRS036 Parasitic Protozoa Infectious Disease 43 0.033
369
NTR042 Neutrophilic Dermatosis, Acute Febrile 38 0.033
370
c OVR114 Ovarian Cancer 1 38 0.033
371
SYS070 Systemic Epstein-Barr Virus-Positive T-Cell Lymphoma of Childhood 36 0.033
372
PRM329 Premature Aging 35 0.033
373
LNT002 Lentigo Maligna Melanoma 33 0.033
374
CRT084 Creatinine Clearance Quantitative Trait Locus 25 0.033
375
PLY179 Polyomavirus-Associated Nephropathy 24 0.033
376
HPT066 Hepatoportal Sclerosis 23 0.033
377
c SCN051 Secondary Pulmonary Alveolar Proteinosis 22 0.033
Content
Loading form....